Related Experiment Video
Updated: Aug 20, 2026

Methylated DNA Immunoprecipitation
Published on: January 2, 2009
Epigenomics and epigenetic therapy of cancer
Robert Brown1, Gordon Strathdee
1Cancer Research UK Dept of Medical Oncology, Beatson Laboratories, Glasgow University, Glasgow, UK G61 1BD. r.brown@beatson.gla.ac.uk
Abstract:
Epigenetic inactivation of genes that are crucial for the control of normal cell growth is a hallmark of cancer cells. These epigenetic mechanisms include crosstalk between DNA methylation, histone modification and other components of chromatin higher-order structure, and lead to the regulation of gene transcription. Re-expression of genes epigenetically inactivated can result in the suppression of tumour growth or sensitization to other anticancer therapies. Small molecules that reverse epigenetic inactivation are now undergoing clinical trials in cancer patients. This, together with epigenomic analysis of chromatin alterations such as DNA methylation and histone acetylation, opens up the potential both to define epigenetic patterns of gene inactivation in tumours and to use drugs that target epigenetic silencing.
Insights
Epigenetic gene silencing is key in cancer. Drugs targeting these epigenetic changes can suppress tumors and improve cancer therapies.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Epigenetic mechanisms, including DNA methylation and histone modification, regulate gene transcription and are crucial for normal cell growth.
- Cancer cells often exhibit epigenetic inactivation of critical growth-control genes.
- Aberrant chromatin structure and gene silencing are hallmarks of cancer.
Purpose of the Study:
- To explore the role of epigenetic inactivation in cancer.
- To investigate the potential of targeting epigenetic mechanisms for cancer therapy.
- To define epigenetic patterns of gene inactivation in tumors.
Main Methods:
- Analysis of chromatin alterations, including DNA methylation and histone acetylation.
- Investigating the effects of small molecules that reverse epigenetic inactivation.
- Epigenomic analysis of tumor samples.
Main Results:
- Epigenetic inactivation of tumor suppressor genes is a common event in cancer.
- Re-expression of epigenetically silenced genes can inhibit tumor growth.
- Drugs targeting epigenetic silencing are in clinical trials for cancer treatment.
Conclusions:
- Epigenetic modifications play a critical role in cancer development and progression.
- Targeting epigenetic mechanisms offers a promising therapeutic strategy for cancer.
- Epigenomic analysis can identify therapeutic targets and guide treatment decisions.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
Mitogens and the Cell Cycle
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Epigenetic Regulation
X-chromosome...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...

